This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is running a campaign to raise awareness of reporting medicine side-effects.
A new study from the Netherlands has looked at the effectiveness of a new sleep seizure detection device. The device – Nightwatch – is a bracelet worn on the arm. It uses heart rate and movement to sense what the authors called ‘major’ seizures.
From today, specialist clinicians can prescribe cannabis-based medicines in the UK to patients with “exceptional clinical need”. They will no longer need to apply to an expert panel for a licence.
The UK government has rescheduled cannabis-based medicines under the Misuse of Drugs regulations 2001. They are now no longer listed under Schedule 1 alongside substances considered to have no therapeutic effect.
The Belfast Trust have announced that a further 1,044 patients previously seen by Consultant Neurologist Dr Michael Watt have been offered review appointments. The review appointments will ensure that these patients are on the correct treatment.
Around 2,500 patients previously under the care of Dr Watt were recalled earlier this year.
The Neurological Alliance is carrying out its third patient experience survey. The alliance is asking people with neurological conditions, such as epilepsy, to share their experiences of neurology services.
The Neurological Alliance is a group of 80 organisations working together to improve services for neurological conditions in England.